=== МЕТАДАННЫЕ ===
{
  "original_filename": "Cardiovascular Manifestations and Immunobiology of Sarcoidosis _ Arteriosclerosis, Thrombosis, and Vascular Biology.html",
  "converted_date": "2026-01-31T14:51:23.629161",
  "file_size_bytes": 457350,
  "original_format": "html",
  "document_type": "Articles",
  "source_folder": "Articles",
  "full_path": "00_RAW_CARDIOLOGY/Articles/Cardiovascular Manifestations and Immunobiology of Sarcoidosis _ Arteriosclerosis, Thrombosis, and Vascular Biology.html"
}

=== СОДЕРЖАНИЕ ===
Cardiovascular Manifestations and Immunobiology of Sarcoidosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Skip to main content
Advertisement
Become a memberVolunteerDonate
JournalsBrowseCollectionsSubjectsAHA Journal PodcastsTrend WatchResourcesCMEAHA Journals @ MeetingsJournal MetricsEarly Career ResourcesInformationFor AuthorsFor ReviewersFor SubscribersFor International UsersAlerts
Shopping cart with
0
item
Cart
Search
Sign in
REGISTER
Quick Search in JournalsEnter search termQuick Search anywhereEnter search termQuick search in CitationsJournalYearVolumeIssuePageSearching:This JournalThis JournalAnywhereCitation
Advanced Search
Search
navigate the sidebar menu
Sign in
REGISTER
Quick Search anywhereEnter search term
Publications
Arteriosclerosis, Thrombosis, and Vascular Biology
Current Issue
Archive
Journal Information
About ATVB
Author
Instructions
Editorial
Board
Meet the Editors
Information for
Advertisers
Features
ATVB_net Blog
ATVB In Focus
Lecture Series
Reviews
Early Career
Resources
ATVB Journal
Awards
Circulation
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Circulation: Arrhythmia and Electrophysiology
Circulation: Cardiovascular Imaging
Circulation: Cardiovascular Interventions
Circulation: Population Health and Outcomes
Circulation: Genomic and Precision Medicine
Circulation: Heart Failure
Stroke: Vascular and Interventional Neurology
Annals of Internal Medicine: Clinical Cases
Information
For Authors
For Reviewers
For Subscribers
For International Users
Submit & Publish
Submit to the AHA
Editorial Policies
Open Science
Value of Many Voices
Publishing with the AHA
Open Access Information
Resources
AHA Journals CME
AHA Journals @ Meetings
Metrics
AHA Journals Podcast Network
Early Career Resources
Trend Watch
Professional Heart Daily
AHA Newsroom
Current Issue
Archive
Journal Information
About ATVB
Author
Instructions
Editorial
Board
Meet the Editors
Information for
Advertisers
Features
ATVB_net Blog
ATVB In Focus
Lecture Series
Reviews
Early Career
Resources
ATVB Journal
Awards
Submit
Reference #1
Review ArticleOriginally Published 18 December 2025Cardiovascular Manifestations and Immunobiology of SarcoidosisNeal L. Weintraub https://orcid.org/0000-0002-5138-3705 nweintraub@augusta.edu, Avirup Guha https://orcid.org/0000-0003-0253-1174, Varsha Taskar, Rachel E. Elam, Austin W.T. Chiang, Klaus Ley https://orcid.org/0000-0001-9339-3672, Gyanendra Sharma https://orcid.org/0000-0001-9027-4440, and Catherine C. Hedrick https://orcid.org/0000-0003-2045-4117Author Info & AffiliationsArteriosclerosis, Thrombosis, and Vascular BiologyVolume 46, Number 2https://doi.org/10.1161/ATVBAHA.125.323111
152MetricsTotal Downloads152Last 12 Months152View all metrics
Track CitationsAdd to favorites
Get AccessContentsAbstractGraphical AbstractSupplemental MaterialReferenceseLettersInformation & AuthorsMetrics & CitationsGet AccessReferencesFiguresTablesMediaShareAbstractSarcoidosis is a chronic inflammatory disease of unknown cause that can affect the heart and blood vessels, causing cardiomyopathy, pulmonary hypertension, and vasculitis. The pathological hallmark of sarcoidosis is the formation of noncaseating granulomas consisting of monocytes and dendritic cells, macrophages, multinucleated giant cells, and T cells. Sarcoidosis has features of autoimmune disease, and many candidate self-epitopes have been identified, but experimental validation is lacking. There is a strong hereditary component associated with the human leukocyte antigen region on chromosome 6. Symptoms of the disease may be subtle and often go unrecognized by patients and practitioners. Catastrophic events, including sudden cardiac death caused by lethal arrhythmias, can be the initial manifestation of the disease. Diagnosis is challenging and limited by the lack of sensitive and specific diagnostic tools, which also hampers monitoring of disease activity. Here, we discuss the cardiovascular manifestations and underlying immunobiology of sarcoidosis. We also review current diagnostic and treatment approaches for cardiac sarcoidosis, as well as the challenges faced by patients and clinicians and opportunities for future research.Graphical AbstractOpen in ViewerGet full access to this articleView all available purchase options and get full access to this article.Get AccessAlready a Subscriber? Sign in as an individual or via your institutionSupplemental MaterialFile (atvb-2025-323111-s02.pdf)Table S1Download40.29 KBReferences1.Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385:1018–1032. doi: 10.1056/NEJMra2101555CrossrefPubMedGoogle Scholar2.Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44:1495–1510. doi: 10.1093/eurheartj/ehad067CrossrefPubMedGoogle Scholar3.Liu A, Price L, Sharma R, Wells A, Kouranos V. Sarcoidosis associated pulmonary hypertension. Biomedicines. 2024;12:177. doi: 10.3390/biomedicines12010177CrossrefPubMedGoogle Scholar4.Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W, Fontenot AP. Genetic, immunologic, and environmental basis of sarcoidosis. Ann Am Thorac Soc. 2017;14:S429–S436. doi: 10.1513/AnnalsATS.201707-565OTCrossrefPubMedGoogle Scholar5.Hena KM. Sarcoidosis epidemiology: race matters. Front Immunol. 2020;11:537382. doi: 10.3389/fimmu.2020.537382CrossrefPubMedGoogle Scholar6.Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147:438–449. doi: 10.1378/chest.14-1120CrossrefPubMedGoogle Scholar7.Fang C, Huang H, Xu Z. Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. PLoS One. 2016;11:e0154716. doi: 10.1371/journal.pone.0154716CrossrefPubMedGoogle Scholar8.Zhou Y, Hu Y, Li H. Role of propionibacterium acnes in sarcoidosis: a meta-analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30:262–267.PubMedGoogle Scholar9.Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007;75:527–530. doi: 10.1128/IAI.00732-06CrossrefPubMedGoogle Scholar10.Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart. 2016;102:184–190. doi: 10.1136/heartjnl-2015-307877CrossrefPubMedGoogle Scholar11.Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–632. doi: 10.1161/CIRCULATIONAHA.114.011522CrossrefPubMedGoogle Scholar12.Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11:26–31.PubMedGoogle Scholar13.Cheng RK, Kittleson MM, Beavers CJ, Birnie DH, Blankstein R, Bravo PE, Gilotra NA, Judson MA, Patton KK, Rose-Bovino L; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation. 2024;149:e1197–e1216. doi: 10.1161/CIR.0000000000001240CrossrefPubMedGoogle Scholar14.Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Organ Assessment Instrument Investigators TW; et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMedGoogle Scholar15.Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA, Judson MA. Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1878–1901. doi: 10.1016/j.jacc.2020.08.042CrossrefPubMedGoogle Scholar16.Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–1323. doi: 10.1016/j.hrthm.2014.03.043CrossrefPubMedGoogle Scholar17.Wahlstrom J, Dengjel J, Persson B, Duyar H, Rammensee HG, Stevanovic S, Eklund A, Weissert R, Grunewald J. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest. 2007;117:3576–3582. doi: 10.1172/JCI32401CrossrefPubMedGoogle Scholar18.Wahlstrom J, Dengjel J, Winqvist O, Targoff I, Persson B, Duyar H, Rammensee HG, Eklund A, Weissert R, Grunewald J. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009;133:353–363. doi: 10.1016/j.clim.2009.08.008CrossrefPubMedGoogle Scholar19.Koltsova EK, Garcia Z, Chodaczek G, Landau M, McArdle S, Scott SR, von Vietinghoff S, Galkina E, Miller YI, Acton ST, et al. Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest. 2012;122:3114–3126. doi: 10.1172/JCI61758CrossrefPubMedGoogle Scholar20.Liu J, Ma P, Lai L, Villanueva A, Koenig A, Bean GR, Bowles DE, Glass C, Watson M, Lavine KJ, et al. Transcriptional and immune landscape of cardiac sarcoidosis. Circ Res. 2022;131:654–669. doi: 10.1161/CIRCRESAHA.121.320449CrossrefPubMedGoogle Scholar21.Lepzien R, Nie M, Czarnewski P, Liu S, Yu M, Ravindran A, Kullberg S, Eklund A, Grunewald J, Smed-Sorensen A. Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNgamma-producing Th1 cells compared with monocytes. J Leukoc Biol. 2022;111:857–866. doi: 10.1002/JLB.5A0321-162RCrossrefPubMedGoogle Scholar22.Garman L, Pelikan RC, Rasmussen A, Lareau CA, Savoy KA, Deshmukh US, Bagavant H, Levin AM, Daouk S, Drake WP, et al. Single cell transcriptomics implicate novel monocyte and T cell immune dysregulation in sarcoidosis. Front Immunol. 2020;11:567342. doi: 10.3389/fimmu.2020.567342CrossrefPubMedGoogle Scholar23.Liao SY, Atif SM, Mould K, Konigsberg IR, Fu R, Davidson E, Li L, Fontenot AP, Maier LA, Yang IV. Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases. Eur Respir J. 2021;57:2003794. doi: 10.1183/13993003.03794-2020CrossrefPubMedGoogle Scholar24.Giladi A, Cohen M, Medaglia C, Baran Y, Li B, Zada M, Bost P, Blecher-Gonen R, Salame TM, Mayer JU, et al. Dissecting cellular crosstalk by sequencing physically interacting cells. Nat Biotechnol. 2020;38:629–637. doi: 10.1038/s41587-020-0442-2CrossrefPubMedGoogle Scholar25.Saigusa R, Roy P, Freuchet A, Gulati R, Ghosheh Y, Suthahar SSA, Durant CP, Hanna DB, Kiosses WB, Orecchioni M, et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat Cardiovasc Res. 2022;1:462–475. doi: 10.1038/s44161-022-00063-3CrossrefPubMedGoogle Scholar26.Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93. doi: 10.1161/CIRCEP.114.002145CrossrefPubMedGoogle Scholar27.Agarwal A, Sulemanjee NZ, Cheema O, Downey FX, Tajik AJ. Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patient. Echocardiogr. 2014;31:E138–E141. doi: 10.1111/echo.12536CrossrefPubMedGoogle Scholar28.Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084. doi: 10.1056/NEJM200004133421502CrossrefPubMedGoogle Scholar29.Lam CS, Tolep KA, Metke MP, Glockner J, Cooper LT. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol. 2009;32:E68–E71. doi: 10.1002/clc.20381CrossrefPubMedGoogle Scholar30.Barton JH, Tavora F, Farb A, Li L, Burke AP. Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery. Cardiovasc Pathol. 2010;19:e119–e123. doi: 10.1016/j.carpath.2009.04.006CrossrefPubMedGoogle Scholar31.Kandolin R, Ekström K, Simard T, Hibbert B, Nery P, Lehtonen J, Kupari M, Birnie D. Spontaneous coronary artery dissection in cardiac sarcoidosis. Oxf Med Case Reports. 2019;2019:omz033. doi: 10.1093/omcr/omz033CrossrefPubMedGoogle Scholar32.Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH. Myocardial blood flow and inflammatory cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10:157–167. doi: 10.1016/j.jcmg.2016.09.023CrossrefPubMedGoogle Scholar33.Bargagli E, Rosi E, Pistolesi M, Lavorini F, Voltolini L, Rottoli P. Increased risk of atherosclerosis in patients with sarcoidosis. Pathobiology. 2017;84:258–263. doi: 10.1159/000477736CrossrefPubMedGoogle Scholar34.Rossides M, Kullberg S, Grunewald J, Eklund A, Di Giuseppe D, Askling J, Arkema EV. Risk of acute myocardial infarction in sarcoidosis: a population-based cohort study from Sweden. Respir Med. 2021;188:106624. doi: 10.1016/j.rmed.2021.106624CrossrefPubMedGoogle Scholar35.Bathla G, Abdel-Wahed L, Agarwal A, Cho TA, Gupta S, Jones KA, Priya S, Soni N, Wasserman BA. Vascular involvement in neurosarcoidosis: early experiences from intracranial vessel wall imaging. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1063. doi: 10.1212/NXI.0000000000001063CrossrefPubMedGoogle Scholar36.Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum. 2000;30:33–46. doi: 10.1053/sarh.2000.8364CrossrefPubMedGoogle Scholar37.Kawano M. Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances. Semin Arthritis Rheum. 2025;72S:152691. doi: 10.1016/j.semarthrit.2025.152691CrossrefPubMedGoogle Scholar38.Siasos G, Tousoulis D, Gialafos E, Oikonomou E, Zaromitidou M, Aggeli C, Korompelis P, Kallianos A, Rapti A, Zisimos K, et al. Association of sarcoidosis with endothelial function, arterial wall properties, and biomarkers of inflammation. Am J Hypertens. 2011;24:647–653. doi: 10.1038/ajh.2011.30CrossrefPubMedGoogle Scholar39.Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol. 1992;23:1216–1223. doi: 10.1016/0046-8177(92)90288-eCrossrefPubMedGoogle Scholar40.Ungprasert P, Crowson CS, Matteson EL. Association of sarcoidosis with increased risk of VTE: a population based study, 1976-2013. Chest. 2017;151:425–430. doi: 10.1016/j.chest.2016.09.009CrossrefPubMedGoogle Scholar41.Lal C, Medarov B, Judson M. Interrelationship between sleep disordered breathing and sarcoidosis. Chest. 2015;148:1105–1114. doi: 10.1378/chest.15-0584CrossrefPubMedGoogle Scholar42.Zhang J, Li Y, Xu Q, Xu B, Wang H. Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis. Can Respir J. 2018;2018:7457369. doi: 10.1155/2018/7457369CrossrefPubMedGoogle Scholar43.Kim SJ, Pak K, Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis. J Nucl Cardiol. 2020;27:2103–2115. doi: 10.1007/s12350-018-01582-yCrossrefPubMedGoogle Scholar44.Obi ON, Lower EE, Baughman RP. Controversies in the treatment of cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2022;39:e2022015. doi: 10.36141/svdld.v39i2.13136CrossrefPubMedGoogle Scholar45.Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, et al; PREDMETH Collaborators. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. N Engl J Med. 2025;393:231–242. doi: 10.1056/NEJMoa2501443CrossrefPubMedGoogle Scholar46.Nunes H, Hindré R, Jeny F. New therapeutic options in sarcoidosis. Curr Opin Pulm Med. 2025;31:560–570. doi: 10.1097/MCP.0000000000001196CrossrefPubMedGoogle ScholarShow all references
eLetterseLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article
Information & AuthorsInformationAuthorsInformationPublished In
Arteriosclerosis, Thrombosis, and Vascular BiologyVolume 46 • Number 2 • February 2026Page: e323111PubMed: 41410048Copyright© 2025 American Heart Association, Inc.VersionsYou are viewing the most recent version of this article.18 December 2025: Ahead of PrintHistoryReceived: 21 August 2025Revision received: 18 November 2025Accepted: 3 December 2025Published online: 18 December 2025Published in print: February 2026PermissionsRequest permissions for this article.Request permissionsKeywordsdendritic cellshypertension, pulmonarymagnetic resonance imagingmonocytessarcoidosisSubjectsInflammationInflammatory Heart DiseasePathophysiologyVascular DiseaseAuthorsAffiliationsExpand AllNeal L. Weintraub https://orcid.org/0000-0002-5138-3705 nweintraub@augusta.eduDivision of Cardiology (N.L.W., A.G., G.S.), Medical College of Georgia at Augusta University.View all articles by this authorAvirup Guha https://orcid.org/0000-0003-0253-1174Division of Cardiology (N.L.W., A.G., G.S.), Medical College of Georgia at Augusta University.View all articles by this authorVarsha TaskarDivision of Pulmonary, Critical Care and Sleep Medicine (V.T.), Medical College of Georgia at Augusta University.View all articles by this authorRachel E. ElamDivision of Rheumatology (R.E.E.), Medical College of Georgia at Augusta University.View all articles by this authorAustin W.T. ChiangDepartment of Medicine, and the Immunology Center of Georgia (A.W.T.C., K.L., C.C.H.), Medical College of Georgia at Augusta University.View all articles by this authorKlaus Ley https://orcid.org/0000-0001-9339-3672Department of Medicine, and the Immunology Center of Georgia (A.W.T.C., K.L., C.C.H.), Medical College of Georgia at Augusta University.View all articles by this authorGyanendra Sharma https://orcid.org/0000-0001-9027-4440Division of Cardiology (N.L.W., A.G., G.S.), Medical College of Georgia at Augusta University.View all articles by this authorCatherine C. Hedrick https://orcid.org/0000-0003-2045-4117Department of Medicine, and the Immunology Center of Georgia (A.W.T.C., K.L., C.C.H.), Medical College of Georgia at Augusta University.View all articles by this authorNotesFor Sources of Funding and Disclosures, see page 356.Supplemental Material is available at Supplemental Material.Correspondence to: Neal L. Weintraub, MD, Division of Cardiology, Department of Medicine, Vascular Biology Center, Medical College of Georgia at Augusta University, 1460 Laney Walker Blvd, Augusta 30912, GA. Email nweintraub@augusta.eduDisclosuresNone.Sources of FundingNone.Metrics & CitationsMetricsCitationsMetrics
Article MetricsView all metricsDownloadsCitationsNo data available.020406080Dec 2025Jan 20261520TotalFirst 90 DaysTotal number of
downloads
See more details
On 2 Facebook pages
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Please select your download format:
RIS (ProCite, Reference Manager)
EndNote
BibTex
Medlars
RefWorks
Direct Import
FiguresOpen all in viewerGo to FigureOpen in ViewerTablesMediaShareShareShare article linkhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.125.323111Copy LinkCopied!Copying failed.ShareFacebookLinkedInX (formerly Twitter)emailWeChatBlueskyGet AccessGet Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login
Institutional Login
Email
Password
Forgot your password? Reset it
here
Keep me logged in
Login
Don’t have an account? Register
here
Save for later
Item saved, go to cart
Purchase Options
Purchase this article to access the full text.
Purchase access to this article for 24 hours
Cardiovascular Manifestations and Immunobiology of Sarcoidosis
Arteriosclerosis, Thrombosis, and Vascular Biology
Vol. 46
No. 2
pp. e323501-
USD
$35.00
Add to Cart
Checkout
Purchase access to this journal for 24 hours
Arteriosclerosis, Thrombosis, and Vascular Biology
Vol. 46
No. 2
pp. e323501-
USD
$40.00
Add to Cart
Checkout
Restore your content access
Enter your email address to restore your content access:
Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.
ReferencesReferencesReferences1.Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385:1018–1032. doi: 10.1056/NEJMra2101555CrossrefPubMedGoogle Scholar2.Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44:1495–1510. doi: 10.1093/eurheartj/ehad067CrossrefPubMedGoogle Scholar3.Liu A, Price L, Sharma R, Wells A, Kouranos V. Sarcoidosis associated pulmonary hypertension. Biomedicines. 2024;12:177. doi: 10.3390/biomedicines12010177CrossrefPubMedGoogle Scholar4.Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W, Fontenot AP. Genetic, immunologic, and environmental basis of sarcoidosis. Ann Am Thorac Soc. 2017;14:S429–S436. doi: 10.1513/AnnalsATS.201707-565OTCrossrefPubMedGoogle Scholar5.Hena KM. Sarcoidosis epidemiology: race matters. Front Immunol. 2020;11:537382. doi: 10.3389/fimmu.2020.537382CrossrefPubMedGoogle Scholar6.Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147:438–449. doi: 10.1378/chest.14-1120CrossrefPubMedGoogle Scholar7.Fang C, Huang H, Xu Z. Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. PLoS One. 2016;11:e0154716. doi: 10.1371/journal.pone.0154716CrossrefPubMedGoogle Scholar8.Zhou Y, Hu Y, Li H. Role of propionibacterium acnes in sarcoidosis: a meta-analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30:262–267.PubMedGoogle Scholar9.Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007;75:527–530. doi: 10.1128/IAI.00732-06CrossrefPubMedGoogle Scholar10.Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart. 2016;102:184–190. doi: 10.1136/heartjnl-2015-307877CrossrefPubMedGoogle Scholar11.Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–632. doi: 10.1161/CIRCULATIONAHA.114.011522CrossrefPubMedGoogle Scholar12.Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11:26–31.PubMedGoogle Scholar13.Cheng RK, Kittleson MM, Beavers CJ, Birnie DH, Blankstein R, Bravo PE, Gilotra NA, Judson MA, Patton KK, Rose-Bovino L; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation. 2024;149:e1197–e1216. doi: 10.1161/CIR.0000000000001240CrossrefPubMedGoogle Scholar14.Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Organ Assessment Instrument Investigators TW; et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMedGoogle Scholar15.Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA, Judson MA. Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1878–1901. doi: 10.1016/j.jacc.2020.08.042CrossrefPubMedGoogle Scholar16.Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–1323. doi: 10.1016/j.hrthm.2014.03.043CrossrefPubMedGoogle Scholar17.Wahlstrom J, Dengjel J, Persson B, Duyar H, Rammensee HG, Stevanovic S, Eklund A, Weissert R, Grunewald J. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest. 2007;117:3576–3582. doi: 10.1172/JCI32401CrossrefPubMedGoogle Scholar18.Wahlstrom J, Dengjel J, Winqvist O, Targoff I, Persson B, Duyar H, Rammensee HG, Eklund A, Weissert R, Grunewald J. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009;133:353–363. doi: 10.1016/j.clim.2009.08.008CrossrefPubMedGoogle Scholar19.Koltsova EK, Garcia Z, Chodaczek G, Landau M, McArdle S, Scott SR, von Vietinghoff S, Galkina E, Miller YI, Acton ST, et al. Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest. 2012;122:3114–3126. doi: 10.1172/JCI61758CrossrefPubMedGoogle Scholar20.Liu J, Ma P, Lai L, Villanueva A, Koenig A, Bean GR, Bowles DE, Glass C, Watson M, Lavine KJ, et al. Transcriptional and immune landscape of cardiac sarcoidosis. Circ Res. 2022;131:654–669. doi: 10.1161/CIRCRESAHA.121.320449CrossrefPubMedGoogle Scholar21.Lepzien R, Nie M, Czarnewski P, Liu S, Yu M, Ravindran A, Kullberg S, Eklund A, Grunewald J, Smed-Sorensen A. Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNgamma-producing Th1 cells compared with monocytes. J Leukoc Biol. 2022;111:857–866. doi: 10.1002/JLB.5A0321-162RCrossrefPubMedGoogle Scholar22.Garman L, Pelikan RC, Rasmussen A, Lareau CA, Savoy KA, Deshmukh US, Bagavant H, Levin AM, Daouk S, Drake WP, et al. Single cell transcriptomics implicate novel monocyte and T cell immune dysregulation in sarcoidosis. Front Immunol. 2020;11:567342. doi: 10.3389/fimmu.2020.567342CrossrefPubMedGoogle Scholar23.Liao SY, Atif SM, Mould K, Konigsberg IR, Fu R, Davidson E, Li L, Fontenot AP, Maier LA, Yang IV. Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases. Eur Respir J. 2021;57:2003794. doi: 10.1183/13993003.03794-2020CrossrefPubMedGoogle Scholar24.Giladi A, Cohen M, Medaglia C, Baran Y, Li B, Zada M, Bost P, Blecher-Gonen R, Salame TM, Mayer JU, et al. Dissecting cellular crosstalk by sequencing physically interacting cells. Nat Biotechnol. 2020;38:629–637. doi: 10.1038/s41587-020-0442-2CrossrefPubMedGoogle Scholar25.Saigusa R, Roy P, Freuchet A, Gulati R, Ghosheh Y, Suthahar SSA, Durant CP, Hanna DB, Kiosses WB, Orecchioni M, et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat Cardiovasc Res. 2022;1:462–475. doi: 10.1038/s44161-022-00063-3CrossrefPubMedGoogle Scholar26.Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93. doi: 10.1161/CIRCEP.114.002145CrossrefPubMedGoogle Scholar27.Agarwal A, Sulemanjee NZ, Cheema O, Downey FX, Tajik AJ. Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patient. Echocardiogr. 2014;31:E138–E141. doi: 10.1111/echo.12536CrossrefPubMedGoogle Scholar28.Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084. doi: 10.1056/NEJM200004133421502CrossrefPubMedGoogle Scholar29.Lam CS, Tolep KA, Metke MP, Glockner J, Cooper LT. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol. 2009;32:E68–E71. doi: 10.1002/clc.20381CrossrefPubMedGoogle Scholar30.Barton JH, Tavora F, Farb A, Li L, Burke AP. Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery. Cardiovasc Pathol. 2010;19:e119–e123. doi: 10.1016/j.carpath.2009.04.006CrossrefPubMedGoogle Scholar31.Kandolin R, Ekström K, Simard T, Hibbert B, Nery P, Lehtonen J, Kupari M, Birnie D. Spontaneous coronary artery dissection in cardiac sarcoidosis. Oxf Med Case Reports. 2019;2019:omz033. doi: 10.1093/omcr/omz033CrossrefPubMedGoogle Scholar32.Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH. Myocardial blood flow and inflammatory cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10:157–167. doi: 10.1016/j.jcmg.2016.09.023CrossrefPubMedGoogle Scholar33.Bargagli E, Rosi E, Pistolesi M, Lavorini F, Voltolini L, Rottoli P. Increased risk of atherosclerosis in patients with sarcoidosis. Pathobiology. 2017;84:258–263. doi: 10.1159/000477736CrossrefPubMedGoogle Scholar34.Rossides M, Kullberg S, Grunewald J, Eklund A, Di Giuseppe D, Askling J, Arkema EV. Risk of acute myocardial infarction in sarcoidosis: a population-based cohort study from Sweden. Respir Med. 2021;188:106624. doi: 10.1016/j.rmed.2021.106624CrossrefPubMedGoogle Scholar35.Bathla G, Abdel-Wahed L, Agarwal A, Cho TA, Gupta S, Jones KA, Priya S, Soni N, Wasserman BA. Vascular involvement in neurosarcoidosis: early experiences from intracranial vessel wall imaging. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1063. doi: 10.1212/NXI.0000000000001063CrossrefPubMedGoogle Scholar36.Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum. 2000;30:33–46. doi: 10.1053/sarh.2000.8364CrossrefPubMedGoogle Scholar37.Kawano M. Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances. Semin Arthritis Rheum. 2025;72S:152691. doi: 10.1016/j.semarthrit.2025.152691CrossrefPubMedGoogle Scholar38.Siasos G, Tousoulis D, Gialafos E, Oikonomou E, Zaromitidou M, Aggeli C, Korompelis P, Kallianos A, Rapti A, Zisimos K, et al. Association of sarcoidosis with endothelial function, arterial wall properties, and biomarkers of inflammation. Am J Hypertens. 2011;24:647–653. doi: 10.1038/ajh.2011.30CrossrefPubMedGoogle Scholar39.Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol. 1992;23:1216–1223. doi: 10.1016/0046-8177(92)90288-eCrossrefPubMedGoogle Scholar40.Ungprasert P, Crowson CS, Matteson EL. Association of sarcoidosis with increased risk of VTE: a population based study, 1976-2013. Chest. 2017;151:425–430. doi: 10.1016/j.chest.2016.09.009CrossrefPubMedGoogle Scholar41.Lal C, Medarov B, Judson M. Interrelationship between sleep disordered breathing and sarcoidosis. Chest. 2015;148:1105–1114. doi: 10.1378/chest.15-0584CrossrefPubMedGoogle Scholar42.Zhang J, Li Y, Xu Q, Xu B, Wang H. Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis. Can Respir J. 2018;2018:7457369. doi: 10.1155/2018/7457369CrossrefPubMedGoogle Scholar43.Kim SJ, Pak K, Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis. J Nucl Cardiol. 2020;27:2103–2115. doi: 10.1007/s12350-018-01582-yCrossrefPubMedGoogle Scholar44.Obi ON, Lower EE, Baughman RP. Controversies in the treatment of cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2022;39:e2022015. doi: 10.36141/svdld.v39i2.13136CrossrefPubMedGoogle Scholar45.Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, et al; PREDMETH Collaborators. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. N Engl J Med. 2025;393:231–242. doi: 10.1056/NEJMoa2501443CrossrefPubMedGoogle Scholar46.Nunes H, Hindré R, Jeny F. New therapeutic options in sarcoidosis. Curr Opin Pulm Med. 2025;31:560–570. doi: 10.1097/MCP.0000000000001196CrossrefPubMedGoogle Scholar
Advertisement
RecommendedNovember 2009Detection of Myocardial Damage in Patients With Sarcoidosis
Manesh R. Patel,
Peter J. Cawley,
John F. Heitner,
Igor Klem,
Michele A. Parker,
Wael A. Jaroudi,
Trip J. Meine,
James B. White,
Michael D. Elliott,
Han W. Kim,
Robert M. Judd, and
[...]Raymond J. Kim
+8 authors
December 2014Cardiac Sarcoidosis
Riina Kandolin,
Jukka Lehtonen,
Juhani Airaksinen,
Tapani Vihinen,
Heikki Miettinen,
Kari Ylitalo,
Kari Kaikkonen,
Suvi Tuohinen,
Petri Haataja,
Tuomas Kerola,
Jorma Kokkonen,
Markus Pelkonen,
Päivi Pietilä-Effati,
Seppo Utrianen, and
[...]Markku Kupari
+11 authors
February 2016Evaluation of Known or Suspected Cardiac Sarcoidosis
Ron Blankstein and
[...]Alfonso H. Waller
+0 authors
Advertisement
Submit a Response to This ArticleCloseCompose eLetterTitle:Comment text:Contributors(all fields are required)Remove ContributorFirst Name:Last Name:Email:Affiliation:Add Another Contributor
Statement of Competing InterestsCompeting Interests?YESNOPlease describe the competing interests
CancelSubmitView full text|Download PDF
Comment Response
Arteriosclerosis, Thrombosis, and Vascular Biology
Submit
Browse
Browse
Collections
Subject Terms
AHA Journal Podcasts
Trend Watch
Resources
Resources
CME
Journal Metrics
Early Career Resources
AHA Journals @ Meetings
Information
Information
For Authors
For Reviewers
For Subscribers
For International Users
Arteriosclerosis, Thrombosis, and Vascular Biology
Circulation
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Circulation: Arrhythmia and Electrophysiology
Circulation: Cardiovascular Imaging
Circulation: Cardiovascular Interventions
Circulation: Population Health and Outcomes
Circulation: Genomic and Precision Medicine
Circulation: Heart Failure
Stroke: Vascular and Interventional Neurology
Annals of Internal Medicine: Clinical Cases
This page is managed by Wolters Kluwer Health, Inc. and/or its affiliates or subsidiaries. Wolters Kluwer Privacy Policy
Your California Privacy Choices
Manage Cookie Preferences
Back to top
National Center
7272 Greenville Ave.Dallas, TX 75231Customer Service
1-800-AHA-USA-1
1-800-242-8721Hours
Monday - Friday: 7 a.m. – 7 p.m. CT
Saturday: 9 a.m. - 5 p.m. CT
Closed on SundaysTax Identification Number
13-5613797
ABOUT
US
About the
AHA/ASA
Annual
report
AHA Financial
Information
Careers
International
Programs
Latest Heart and
Stroke News
AHA/ASA Media
Newsroom
GET
INVOLVED
Donate
Advocate
Volunteer
ShopHeart
ShopCPR
OUR
SITES
American Heart
Association
American Stroke
Association
CPR &
ECC
Go Red For
Women
More
Sites
AHA Careers
AHA Privacy Policy
Medical Advice Disclaimer
Copyright Policy
Accessibility Statement
Ethics Policy
Conflict of Interes Policy
Linking Policy
Whistleblower Policy
Content Editorial Guidelines
Diversity
Suppliers & Providers
State Fundraising Notices
©2026 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.The
American Heart Association is a qualified 501(c)(3) tax-exempt organization.*Red Dress ™ DHHS, Go Red ™
AHA ; National Wear Red Day® is a registered trademark.
Copy link✓Thanks for sharing!Find any serviceAddToAnyMore…Privacy Preference CenterWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences. However, blocking some types of cookies may impact your experience on the site and the services we are able to offer.
Privacy & Cookie NoticeManage Consent PreferencesStrictly Necessary CookiesAlways ActiveThese cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site.View Vendor Details‎Functional Cookies
Functional Cookies These cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly.View Vendor Details‎Performance Cookies
Performance Cookies These cookies support analytic services that measure and improve the performance of our site. They
help us know which pages are the most and least popular and see how visitors move around the site.View Vendor Details‎Advertising Cookies
Advertising Cookies These cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers.
If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests.View Vendor Details‎Back ButtonVendors List Search IconFilter IconClear checkbox label labelApply CancelConsent Leg.Interest checkbox label label checkbox label label checkbox label labelAllow AllReject All Confirm My Choices
Now Reading:Cardiovascular Manifestations and Immunobiology of SarcoidosisTrack CitationsAdd to favoritesShareGet AccessPREVIOUS ARTICLEVascular Toxicities of Cancer Therapies: 2025 UpdatePreviousNEXT ARTICLEPotential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever VirusesNext__("articleCrossmark.closePopup")
